2000
DOI: 10.1038/sj.sc.3101074
|View full text |Cite
|
Sign up to set email alerts
|

Effects of methylprednisolone and MK-801 on functional recovery after experimental chronic spinal cord injury

Abstract: Study design: An experimental study was conducted to evaluate the eects of methylprednisolone and MK-801 after the compressive injury of spinal cord in rats. Objectives: To investigate the eect of methylprednisolone and non-competitive NMDA antagonist MK-801 in long-term functional outcome after spinal cord injury (SCI). Methods: A randomized group A of Sprague-Dawley rats were treated with MK-801 (1.0 mg/kg, n=10; Group A) after a compression injury. A group of methylprednisolone (MP)-treated (30 mg/kg, n=10;… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 34 publications
0
19
0
Order By: Relevance
“…Although MK-801 prevents some SCI-induced cell loss (Liu et al, 1997;Wada et al, 1999), it does not improve blood flow, edema, or locomotor function (Li and Tator, 1999;Haghighi et al, 2000;Li and Tator, 2000). Our results (Tables III-VI and VIII) offer one explanation for the lack of long-term beneficial effects for MK-801 treatment on SCI outcomes.…”
Section: Noninjury-related Effects Of Mk-801 On Spinal Cord Expressiomentioning
confidence: 49%
“…Although MK-801 prevents some SCI-induced cell loss (Liu et al, 1997;Wada et al, 1999), it does not improve blood flow, edema, or locomotor function (Li and Tator, 1999;Haghighi et al, 2000;Li and Tator, 2000). Our results (Tables III-VI and VIII) offer one explanation for the lack of long-term beneficial effects for MK-801 treatment on SCI outcomes.…”
Section: Noninjury-related Effects Of Mk-801 On Spinal Cord Expressiomentioning
confidence: 49%
“…17 The development of such therapeutics may be assisted with the delineation SCI mechanisms and their relationship to column injury patterns. It is hoped that clinical therapies may eventually achieve greater success if they are targeted to specific structures damaged by these distinct injury mechanisms.…”
Section: Discussionmentioning
confidence: 99%
“…First, the dose of rolipram most effective as an antiinflammatory agent is 3-to 6-fold higher than the optimal dose we report here for functional recovery after spinal cord injury (22)(23)(24). Second, methylprednisolone, a known antiinflammatory already used as a therapy in humans, prevents some secondary cell loss in animal models of spinal cord injury but does not produce any significant improvement in functional recovery (25)(26)(27) Regardless, of the mechanism of action, rolipram is effective and should be considered as a therapy for spinal cord injury. It is of note that rolipram is effective at lower but not at high doses, for both the culture and the in vivo assays.…”
Section: Discussionmentioning
confidence: 99%